Skip to main content
Fig. 2 | BMC Rheumatology

Fig. 2

From: Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis

Fig. 2

Self-reported scores (predicted marginal means) during the first year of treatment for the three responder groups: A modified Health Assessment Questionnaire (mHAQ) disability B Fatigue (measured in 0–100 mm visual analogue scale) C Helplessness in coping with arthritis (measured in a 5–30 subscale scoring system in a Validated 5-item Rheumatology Attitudes Index (VALI-RAI))

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us